Abstract
A single EEG measure of drug effect, the spectral difference index (SDI), was compared to other quantitative measures for its sensitivity to drugs from 7 different clinical classes. The other measures included relative power in 2 c/sec bands from 0 to 17 c/sec, and in 4 c/sec bands from 18 to 29 c/sec; relative power and average frequency in the bands 1–5, 6–13 and 14–30 c/sec; and the Hjorth time domain descriptors. The SDI was the most sensitive EEG discriminator between drug and placebo sessions. It is presently used in our pharmaco-EEG studies to test whether a drug has significantly altered the EEG. Its use has been extended to interhemispheric studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Electroencephalography and Clinical Neurophysiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
